Document Detail


A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne.
MedLine Citation:
PMID:  24509968     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Three multicenter, randomized, double blind, parallel-group, placebo controlled studies involving 3,855 subjects established the safety and efficacy of an adapalene benzoyl peroxide topical gel in the treatment of acne for all skin types. The data from these 3 studies were pooled and the subgroup of self-identified black subjects was analyzed separately. Significantly more black subjects had IGA success with adapalene-BPO than with vehicle at week 12. Significantly more black subjects also had decreased total, inflammatory, and noninflammatory lesion counts with adapalene-BPO that were seen as early as week 1. Adapalene-BPO was well tolerated in the black subjects included in this analysis and no cases of treatment-related PIH were observed. Similar results were obtained for this subgroup as the overall population from the 3 studies. Based on the results from this analysis, adapalene-BPO is a safe and effective treatment for acne in black skin.<BR /><BR /> <EM>J Drugs Dermatol.</EM> 2014;13(2):170-174.
Authors:
Andrew F Alexis; Lori A Johnson; Nabil Kerrouche; Valerie D Callender
Related Documents :
8552118 - Screening parkinson's disease: a validated questionnaire of high specificity and sensit...
16968828 - Oxcarbazepine use in essential tremor.
22776348 - A group-theoretical notation for disease states: an example using the psychiatric ratin...
17982908 - Association of parkinson's disease with symptoms of attention deficit hyperactivity dis...
15864028 - Congenital vertical talus in arthrogryposis and other contractural syndromes.
23376998 - Sympathetic nervous system responses to acupuncture and non-penetrating sham acupunctur...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  13     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-02-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  170-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: two phase 3,multicenter, randomized...
Next Document:  The prophylactic use of a topical scar gel containing extract of allium cepae, allantoin, and hepari...